We and others have demonstrated that the expression of the BAD-mediated apoptotic pathway and the phosphorylation status of the BAD protein influence the chemosensitivity of cancer cells, including ovarian and endometrial cancer cells (3,4,6,14). This evidence concerns the gene BAD and cancer.